Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare Biotechnology

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd > Crystal Research Report

<< Previous

Bullboard Posts

Next >>

Comment by JAKPUG4LIFEon Mar 10, 2022 4:01pm

65 Views

Post# 34504290

RE:RE:RE:Crystal Research Report

Yes and all good institutional investors will not be looking up FSD with the many failures in the past to go along with zero shareholder value. More wasted money imo

DavidRosenberg wrote:
JAKPUG4LIFE wrote: Wonder how much this cost investors? By the way is this promotion part of the 6-8 we already have contracts with to promote which cost us investors millions and milillions of dollars including shares on top of that. Dave?

DavidRosenberg wrote: https://bit.ly/3CEF7Cr

All good institutional investors use these reports as a quick guide to analyze their data if they come accross FSD in their research